Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;279(2):773-777.
doi: 10.1007/s00405-021-06848-9. Epub 2021 May 3.

Smell impairment in patients with chronic rhinosinusitis: a real-life study

Affiliations

Smell impairment in patients with chronic rhinosinusitis: a real-life study

Giulio Cesare Passali et al. Eur Arch Otorhinolaryngol. 2022 Feb.

Abstract

Objective: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a frequently occurring condition involving type 2 inflammation. It has a global prevalence of approximately 4% and has a major effect on the quality of life of those affected by it. CRSwNP is a complex condition for otorhinolaryngologists to manage, since its precise pathogenic basis has not been established, treatment is challenging and the condition often recurs. It is common to find abnormalities in smelling in those with CRSwNP.

Materials and methods: This cross-sectional study enrolled patients suffering from CRS. Three groups were compared: 1812 patients with CRS, 571 with CRSwNP, and 120 with CRSwNP treated by FESS. The Sniffin' Sticks® olfactory test was used to measure olfactory function in all patients.

Results: Olfactory dysfunction was a common symptom in patients with CRS, ranging in frequency from 56 to 74%. In patients with CRSwNP, impairment of sense of smell affected 64% of subjects (42% with anosmia, 10% with hyposmia, and 12% with cacosmia). After surgery, there was a significant improvement in the ability to smell normally.

Conclusion: The present study confirms that impairment of smell is a common symptom in patients with chronic rhinosinusitis, mainly in subjects with nasal polyps. FESS reduces the prevalence of olfactory dysfunction.

Keywords: Biologics; Chronic rhinosinusitis; Nasal polyps; Olfactory dysfunction; Real-life setting.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Tomassen P, Vandeplas G, Van Zele T, Cardell LO, Arebro J, Olze H et al (2016) Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol 137(5):1449-1456.e4 - DOI
    1. Bachert C, Zhang N, Holtappels G, De Lobel L, van Cauwenberge P, Liu S et al (2010) Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J Allergy Clin Immunol 126:962–968 - DOI
    1. Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA et al (2006) Rhinosinusitis: developing guidance for clinical trials Rhinosinusitis Initiative. J Allergy Clin Immunol 118(5 Suppl):S17-61 - DOI
    1. Lund VJ, Kennedy DW (1997) Staging for rhinosinusitis. Otolaryngol Head Neck Surg 117:S35-40 - DOI
    1. Gelardi M, Russo C, Fiorella ML, Fiorella R, Ciprandi G (2010) Inflammatory cell types in nasal polyps. Cytopathology 2:201–203

LinkOut - more resources